Singapore · 
What does iGlobe Partners invest in?
iGlobe Partners invests most often at Series A and Series B (63% of the rounds on record), in sectors such as Life Science, Gene Therapy and Pharmaceuticals.
iGlobe Partners highlights
- 01
2 cheques in the last 12 months
- 02
Mostly Series A and Series B: 63% of its rounds
- 03
Led 1 rounds
- 04
1 exits from the portfolio
What they do
We unearth, invest and grow startups into global leaders.From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- $500K – $10M as they say
- Stages
- Pre-seedSeedSeries ASeries BGrowth
- Sectors
- Life ScienceGene TherapyPharmaceuticals
- Based in
- Singapore, Singapore
- Cold pitches
- Accepted
The record
Every round we can evidence, newest first17 appearances
- 2026
2 rounds
- Jul
- Mar
- 2021
1 round
- May
- 2015
4 rounds
- May
- Apr
- Mar
- Feb
- 2013
2 rounds
- Dec
- Sept
- 2011
1 round
- Jul
- 2007
1 round
- Nov
- 2006
2 rounds
- Sept
- Jan
- 2005
2 rounds
- Oct
- Aug
- 2004
1 round
- Jan
- 2003
1 round
- Mar
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
We hold 29 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What they claim to have backed
From their own portfolio page (on their website)
14 of 21 we have independently watched raise
Accession TherapeuticsAccredifyDocquityFive SigmaGinkgo BioworksHippoHuueInkbitMatterworksMindfiNovelshipPartipostSwat MobilityTonikAcslAisphereAliro QuantumApplied Angstrom TechnologyEclipsebioNura StudiosSourcesage
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Exits from the portfolio
Companies it backed that were later bought or listed1 in all
TelenavListedUndisclosedMay 2010
An exit counts when it came after the firm's first round in the company. From historical deal records.